Penumbra Revenue 2014-2024 | PEN

Penumbra annual/quarterly revenue history and growth rate from 2014 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Penumbra revenue for the quarter ending September 30, 2024 was $0.301B, a 11.11% increase year-over-year.
  • Penumbra revenue for the twelve months ending September 30, 2024 was $1.164B, a 16.96% increase year-over-year.
  • Penumbra annual revenue for 2023 was $1.059B, a 24.95% increase from 2022.
  • Penumbra annual revenue for 2022 was $0.847B, a 13.32% increase from 2021.
  • Penumbra annual revenue for 2021 was $0.748B, a 33.4% increase from 2020.
Penumbra Annual Revenue
(Millions of US $)
2023 $1,059
2022 $847
2021 $748
2020 $560
2019 $547
2018 $445
2017 $334
2016 $263
2015 $186
2014 $126
2013 $89
Penumbra Quarterly Revenue
(Millions of US $)
2024-09-30 $301
2024-06-30 $299
2024-03-31 $279
2023-12-31 $285
2023-09-30 $271
2023-06-30 $261
2023-03-31 $241
2022-12-31 $221
2022-09-30 $214
2022-06-30 $208
2022-03-31 $204
2021-12-31 $204
2021-09-30 $190
2021-06-30 $184
2021-03-31 $169
2020-12-31 $167
2020-09-30 $151
2020-06-30 $105
2020-03-31 $137
2019-12-31 $145
2019-09-30 $140
2019-06-30 $134
2019-03-31 $128
2018-12-31 $121
2018-09-30 $112
2018-06-30 $110
2018-03-31 $103
2017-12-31 $96
2017-09-30 $84
2017-06-30 $81
2017-03-31 $73
2016-12-31 $73
2016-09-30 $67
2016-06-30 $65
2016-03-31 $58
2015-12-31 $54
2015-09-30 $50
2015-06-30 $42
2015-03-31 $39
2014-12-31
2014-09-30 $32
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.559B $1.059B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.293B 24.68
Intuitive Surgical (ISRG) United States $195.881B 102.41
Edwards Lifesciences (EW) United States $43.763B 27.79
Alcon (ALC) Switzerland $43.327B 28.99
IQVIA Holdings (IQV) United States $36.875B 20.32
IDEXX Laboratories (IDXX) United States $35.573B 41.89
DexCom (DXCM) United States $31.642B 47.65
Waters (WAT) United States $23.237B 34.36
STERIS (STE) Ireland $21.444B 24.69
SONOVA HOLDING (SONVY) Switzerland $20.134B 0.00
Hologic (HOLX) United States $17.445B 18.84
Fresenius Medical Care AG KGaA (FMS) Germany $13.790B 14.16
Sysmex ADR (SSMXY) Japan $13.236B 41.51
Globus Medical (GMED) United States $11.494B 29.11
Masimo (MASI) United States $9.193B 44.48
Teleflex (TFX) United States $8.700B 13.88
Glaukos (GKOS) United States $7.624B 0.00
PROCEPT BioRobotics (PRCT) United States $5.190B 0.00
Integer Holdings (ITGR) United States $4.713B 26.71
Veracyte (VCYT) United States $3.417B 102.54
Inari Medical (NARI) United States $3.056B 0.00
LivaNova (LIVN) United Kingdom $2.780B 16.05
TransMedics (TMDX) United States $2.423B 76.82
Nihon Kohden (NHNKY) Japan $2.410B 18.31
Elekta AB (EKTAY) Sweden $2.150B 19.33
Tandem Diabetes Care (TNDM) United States $2.120B 0.00
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
RxSight (RXST) United States $1.740B 0.00
Alphatec Holdings (ATEC) United States $1.425B 0.00
Artivion (AORT) United States $1.243B 82.36
Pulse Biosciences (PLSE) United States $1.217B 0.00
OPKO Health (OPK) United States $1.065B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.878B 14.92
Paragon 28 (FNA) United States $0.830B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.716B 0.00
IRadimed (IRMD) United States $0.693B 37.48
Mesa Laboratories (MLAB) United States $0.686B 16.17
AxoGen (AXGN) United States $0.653B 0.00
OrthoPediatrics (KIDS) United States $0.591B 0.00
SiBone (SIBN) United States $0.578B 0.00
Pacific Biosciences Of California (PACB) United States $0.570B 0.00
Semler Scientific (SMLR) United States $0.525B 30.93
Treace Medical Concepts (TMCI) United States $0.502B 0.00
Tactile Systems Technology (TCMD) United States $0.456B 24.70
Delcath Systems (DCTH) United States $0.365B 0.00
CVRx (CVRX) United States $0.359B 0.00
ClearPoint Neuro (CLPT) United States $0.351B 0.00
NeuroPace (NPCE) United States $0.334B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.243B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.204B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.181B 0.00
Nevro (NVRO) United States $0.155B 0.00
Atossa Genetics (ATOS) United States $0.147B 0.00
Sensus Healthcare (SRTS) United States $0.142B 15.16
Spectral Diagnostics (EDTXF) Canada $0.110B 0.00
Vicarious Surgical (RBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
908 Devices (MASS) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.085B 0.00
Monogram Orthopaedics (MGRM) United States $0.081B 0.00
Covalon Technologies (CVALF) Canada $0.074B 0.00
InspireMD (NSPR) Israel $0.074B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.052B 0.00
Rapid Micro Biosystems (RPID) United States $0.046B 0.00
Accelerate Diagnostics (AXDX) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.040B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.014B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00